Cargando…

MBNL1(42) and MBNL1(43) gene isoforms, overexpressed in DM1-patient muscle, encode for nuclear proteins interacting with Src family kinases

Myotonic dystrophy type-1 (DM1) is the most prevalent form of muscular dystrophy in adults. This disorder is an RNA-dominant disease, caused by expansion of a CTG repeat in the DMPK gene that leads to a misregulation in the alternative splicing of pre-mRNAs. The longer muscleblind-like-1 (MBNL1) tra...

Descripción completa

Detalles Bibliográficos
Autores principales: Botta, A, Malena, A, Tibaldi, E, Rocchi, L, Loro, E, Pena, E, Cenci, L, Ambrosi, E, Bellocchi, M C, Pagano, M A, Novelli, G, Rossi, G, Monaco, H L, Gianazza, E, Pantic, B, Romeo, V, Marin, O, Brunati, A M, Vergani, L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3763452/
https://www.ncbi.nlm.nih.gov/pubmed/23949219
http://dx.doi.org/10.1038/cddis.2013.291
Descripción
Sumario:Myotonic dystrophy type-1 (DM1) is the most prevalent form of muscular dystrophy in adults. This disorder is an RNA-dominant disease, caused by expansion of a CTG repeat in the DMPK gene that leads to a misregulation in the alternative splicing of pre-mRNAs. The longer muscleblind-like-1 (MBNL1) transcripts containing exon 5 and the respective protein isoforms (MBNL1(42–43)) were found to be overexpressed in DM1 muscle and localized exclusively in the nuclei. In vitro assays showed that MBNL1(42–43) bind the Src-homology 3 domain of Src family kinases (SFKs) via their proline-rich motifs, enhancing the SFK activity. Notably, this association was also confirmed in DM1 muscle and myotubes. The recovery, mediated by an siRNA target to Ex5-MBNL1(42–43), succeeded in reducing the nuclear localization of both Lyn and MBNL1(42–43) proteins and in decreasing the level of tyrosine phosphorylated proteins. Our results suggest an additional molecular mechanism in the DM1 pathogenesis, based on an altered phosphotyrosine signalling pathway.